title: [Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals].
abstract: OBJECTIVE
  To investigate the current statin use among high-risk patients with atherosclerotic cardiovascular diseases in Chinese large hospitals.
  
  
  METHODS
  Clinical history and current medication were recorded in 11 783 patients with a history of atherosclerotic cardiovascular disease (CVD) from 39 highest-ranking hospitals in 10 Chinese cities.
  
  
  RESULTS
  Indication for statin use was given for all screened patients and statin was not prescribed in up to 59.6% (7022) patients. For patients with statin use, medication time was shorter than their atherosclerotic CVD history in 1120 (23.5%) patients. The proportion of statin use among patients with ischemic stroke was 19.6%, among patients with coronary heart disease without ischemic stroke was 59.2%.
  
  
  CONCLUSIONS
  Statin is underused in secondary prevention among patients with atherosclerotic CVD in China. There is a large gap between guideline recommended statin use and in practice. Thus, it remains a major challenge for healthcare professionals and policy makers to resolve this problem rapidly.
authors.affiliation: China Oxford Centre for International Health Research Cardiovascular Institute, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
authors.forename: Dan
authors.initials: D
authors.lastname: Zhang
authors.forename: Lei
authors.initials: L
authors.lastname: Ge
authors.forename: Jing
authors.initials: J
authors.lastname: Li
authors.forename: Xi
authors.initials: X
authors.lastname: Li
authors.forename: Fang
authors.initials: F
authors.lastname: Feng
authors.forename: Yi-ping
authors.initials: YP
authors.lastname: Chen
authors.forename: Zheng-ming
authors.initials: ZM
authors.lastname: Chen
authors.forename: Landray
authors.initials: L
authors.lastname: Martin
authors.forename: Armitage
authors.initials: A
authors.lastname: Jane
authors.forename: Fang
authors.initials: F
authors.lastname: Chen
authors.forename: Li-xin
authors.initials: LX
authors.lastname: Jiang
mesh_terms: D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002681:China; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D006761:Hospitals; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D055502:Secondary Prevention
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors